WHO Drug Information Vol. 20, No. 1, 2006 - World Health ...

More documents

Recommendations

Info

WHO Drug Information, Vol. 20, No. 1, 2006 Recommended INN: List 55zalutumumabumzalutumumabzalutumumabzalutumumabimmunoglobulin G1, anti-(human epidermal growth factorreceptor)(human monoclonal 2F8 heavy chain), disulfide with humanmonoclonal 2F8 κ-chain, dimerimmunoglobuline G1, anti-(récepteur du facteur de croissanceépidermal humain), dimère du disulfure entre la chaîne lourde et lachaîne κ de l’anticorps monoclonal humain 2F8inmunoglobulina G1, anti-(receptor del factor de crecimientoepidérmico humano), dímero del disulfuro entre la cadena pesada yla cadena κ del anticuerpo monoclonal humano 2F8C 6512H 10074N 1734O 2032S 4657
Recommended INN: List 55 WHO Drug Information, Vol. 20, No. 1, 2006AMENDMENTS TO PREVIOUS LISTSMODIFICATIONS APPORTÉES AUX LISTES ANTÉRIEURESMODIFICACIONES A LAS LISTAS ANTERIORESRecommended International Nonproprietary Names (Rec. INN): List 30Dénominations communes internationales recommandées (DCI Rec.): Liste 30Denominaciones Comunes Internacionales Recomendadas (DCI Rec.): Lista 30(WHO Drug Information, Vol. 4, No. 3, 1990)p. 2 artesunatumartesunateartésunateartesunatoinsert the following graphic formula:insérer la formule graphique suivante:insertáse la fórmula desarollada por la siguiente:HCH 3HOCO 2 HHH 3 CHOOHOHOCH 3ORecommended International Nonproprietary Names (Rec. INN): List 43Dénominations communes internationales recommandées (DCI Rec.): Liste 43Denominaciones Comunes Internacionales Recomendadas (DCI Rec.): Lista 43(WHO Drug Information, Vol. 14, No. 1, 2000)p. 70 suprimase insértesetezosentanotezosentánProcedure and Guiding Principles / Procédure et Directives / Procedimientos y principios generalesThe text of the Procedures for the Selection of Recommended International Nonproprietary Names for PharmaceuticalSubstances and General Principles for Guidance in Devising International Nonproprietary Names for PharmaceuticalSubstances will be reproduced in proposed INN lists only.Les textes de la Procédure à suivre en vue du choix de dénominations communes internationales recommandées pour lessubstances pharmaceutiques et des Directives générales pour la formation de dénominations communes internationalesapplicables aux substances pharmaceutiques seront publiés seulement dans les listes des DCI proposées.El texto de los Procedimientos de selección de denominaciones comunes internacionales recomendadas para las sustanciasfarmacéuticas y de los Principios generales de orientación para formar denominaciones comunes internacionales parasustancias farmacéuticas aparece solamente en las listas de DCI propuestas.58
Page 1 and 2:
WHODRUGINFORMATIONV O L U M E 20•
Page 3 and 4:
World Health OrganizationWHO Drug I
Page 5 and 6:
Counterfeit MedicinesWHO Drug Infor
Page 7 and 8: Biological MedicinesWHO Drug Inform
Page 9 and 10: Biological MedicinesWHO Drug Inform
Page 11 and 12: Safety and Efficacy IssuesWHO Drug
Page 21 and 22: Access to MedicinesWHO Drug Informa
Page 27 and 28: WHO Drug Information Vol 20, No. 1,
Page 29 and 30: Regulatory Action and NewsWHO Drug
Page 31 and 32: Recent Publications, Information an
Page 33 and 34: Recent Publications, Information an
Page 35 and 36: General InformationWHO Drug Informa
Page 37 and 38: General InformationWHO Drug Informa
Page 39 and 40: Recommended INN: List 55 WHO Drug I
Page 57: Recommended INN: List 55 WHO Drug I
show all

WHO Drug Information Vol. 20, No. 1, 2006 - World Health ...

Create successful ePaper yourself

Delete template?

Save as template?